Skip to main content

Valrubicin Dosage

Medically reviewed by Last updated on Apr 23, 2021.

Applies to the following strengths: 40 mg/mL

Usual Adult Dose for:

Additional dosage information:

Usual Adult Dose for Urinary Tumor

Usual Adult Dose: 800 mg administered intravesically once a week for six weeks.


  • Delay administration at least two weeks after transurethral resection and/or fulguration.
  • Patients should retain the drug for two hours before voiding, if they are able. At the end of two hours, all patients should void.

Use: For intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Storage requirements:

  • Refrigerate
  • Do not heat vials.

Reconstitution/preparation techniques: The manufacturer product information should be consulted.

  • Monitor closely for disease recurrence or progression.
  • Recommended evaluations include cystoscopy, biopsy, and urine cytology every 3 months.

Patient advice:
  • Patients should maintain adequate hydration following treatment.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.